Apollo Endosurgery, Inc. (NasdaqGM: APEN)
Health Care · Health Care Equipment & Supplies · US
$—
— today · — 1Y
Apollo Endosurgery, Inc. (NasdaqGM: APEN) operates in the Health Care Equipment & Supplies industry within the Health Care sector.
Tweenvest scores Apollo Endosurgery, Inc. across four factors: quality 26/100, growth 36/100. Its strongest factor is growth.
APEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $76.86M
- P/E
- —
- EPS
- -0.98
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 202
- Next earnings
- —
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.
- ISIN
- US03767D1081
- Founded
- 2005
- Listed since
- Apr 21, 2005
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $197.44B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $130.86B | $370.42 | -0.38% |
| Stryker CorporationNYSE: SYK | $126.45B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $117.78B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.25B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $69.81B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.40B | ¥24,965.00 | -0.12% |
| Edwards Lifesciences CorporationNYSE: EW | $52.33B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.